Related Experiment Video
Updated: Feb 21, 2026

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
Use of transfer factor in immunosuppressed surgical patients
Celia Regina Oliveira Garritano1, Francesco di Nubila1, Renata M Couto1
1- Federal University of the State of Rio de Janeiro (UNIRIO), Department of General and Specialized Surgery / Master's Degree in Medicine, Rio de Janeiro, RJ, Brazil.
Objective:
to evaluate the action of Transfer Factor on the immune response of patients with malignant neoplasm submitted to surgery, chemotherapy and radiotherapy.
Method:
we analyzed the variations of leukocytes, total lymphocytes, T-lymphocytes and CD4 counts in 60 patients submitted to immunostimulation with a single, daily dose of 0.5mg sublingual Transfer Factor, started simultaneously with chemotherapy and/or radiotherapy.
Results:
there were statistically significant increases in the counts of all cell lines studied, more pronounced after 12 months of use of the medication.
Conclusion:
the Transfer Factor restored immune response and showed no side effects.
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management

